Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q4 FY20 results · Jan–Mar 2020
Metropolis Healthcare reported revenue from operations of ₹206.97 crore and net profit of ₹15.49 crore for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 206.97 | 0.00 | — | 222.85 | −7.1% |
| Other income | 3.07 | 0.00 | — | 2.19 | +40.3% |
| Total income | 210.05 | 0.00 | — | 225.04 | −6.7% |
| Profit before tax | 23.39 | 0.00 | — | 52.80 | −55.7% |
| Net profit for the period | 15.49 | 0.00 | — | 42.01 | −63.1% |
| EPS, basic (₹) | 3.09 | 0.00 | — | 8.38 | −63.1% |
| Net margin (%) | 7.5 | — | 18.9 |
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 163.16 | 0.00 | — | 172.91 | −5.6% |
| Other income | 25.72 | 0.00 | — | 1.78 | 14x |
| Total income | 188.88 | 0.00 | — | 174.69 | +8.1% |
| Profit before tax | 34.94 | 0.00 | — | 39.99 | −12.6% |
| Net profit for the period | 29.76 | 0.00 | — | 32.30 | −7.9% |
| EPS, basic (₹) | 5.93 | 0.00 | — | 6.44 | −7.9% |
| Net margin (%) | 18.2 | — | 18.7 |
Consolidated
- Filed with BSE
- 30 May 2020, 16:32 IST
- Board meeting
- 29 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 May 2020, 16:32 IST
- Board meeting
- 29 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE